Physician profile
John Goggin
NPI 1740238351
$3,130.07
in general payments reported to CMS, 2019-2025
21 companies · $127 in 2025
The $127 reported for 2025 was less than what a typical Foot & Ankle Surgery provider received nationally (typical 2025 total: $424).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $712 · 2020: $154 · 2021: $1,445 · 2022: $227 · 2023: $331 · 2024: $134 · 2025: $127.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $592.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $591.73 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $1,416.88 | 2021-2023 | Nuzyra |
| Organogenesis INC. | $393.96 | 2019-2022 | |
| Smith+Nephew, INC. | $228.44 | 2019-2025 | Collagenase Santyl, Grafix Pl |
| Djo, LLC | $207.75 | 2021-2025 | Cmf |
| Stryker Corporation | $134.21 | 2024 | Citrefix |
| Merck Sharp & Dohme LLC | $124.99 | 2019 | |
| Grt US Holding, INC. | $89.83 | 2022 | |
| Cardiovascular Systems INC. | $84.93 | 2019 | |
| Horizon Therapeutics Plc | $53.43 | 2019 | |
| Kerecis Limited | $52.81 | 2022-2025 | Kerecis Surgiclose, Kerecis Omega3 Surgiclose, Kerecis Omega3 Graftguide |
| Nevro Corp. | $51.07 | 2022-2023 | Senza |
| Osiris Therapeutics INC. | $47.25 | 2019 | |
| Melinta Therapeutics, LLC | $47.25 | 2019 | |
| Pfizer INC. | $44.22 | 2019-2020 | |
| Urgo Medical North America, LLC | $31.27 | 2025 | Urgok2, Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioventus LLC | $29.78 | 2021-2022 | |
| Convatec INC. | $29.09 | 2023 | |
| Solventum Corporation | $22.93 | 2025 | Activ.A.C. |
| Orthofix Medical, INC. | $18.71 | 2019 | |
| Arthrosurface Incorporated | $15.55 | 2019 | |
| Next Science LLC | $5.72 | 2023 | Surgx, Xperience, Blastx |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw John Goggin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.